Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - Study design

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 8, 2009, Pages 987-994

  Marrouche, Nassir F ^a,c   Brachmann, Johannes ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b KLINIKUM COBURG   (Germany)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Ablation; Atrial fibrillation; Catheter; Ventricular dysfunction

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ANALYSIS; ARTICLE; AUSTRALIA; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR SYSTEM; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSIVE THERAPY; DEFIBRILLATOR; EUROPE; EVALUATION; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART RIGHT VENTRICLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; MULTICENTER STUDY; PULMONARY VEIN OBSTRUCTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOUTH AMERICA; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PULMONARY VEINS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 68449085909     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02428.x     Document Type: Article

References (26)

1. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 2006 114 : 700 752.
2. Roy D, Talajic M, Dorian P, Connolly S, Eisemberg MJ, Green M, Kus T, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med 2000 342 : 913 920.
3. AFFIRM First Antiarrhythmic Drug Sub Study Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM sub study of the first antiarrhythmic drug. J Am Coll Cardiol 2003 42 : 20 29.
4. Chun SH, Sager PT, Stevenson WG, Nadamanee K, Middlekauff HR, Singh BN. Long-term efficacy of Amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995 76 : 47 50.
5. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, et al., Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) investigators. N Engl J Med 2002 347 : 1825 1833.
6. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. Rate control versus electrical cardioversion for persistent atrial fibrillation study group. N Engl J Med 2002 347 : 1834 1840.
7. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, et al., for the STAF Study Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003 41 : 1690 1696. (Pubitemid 36584236)
8. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation: Pharmacological intervention in atrial fibrillation (PIAF): A randomized trial. Lancet 2000 356 : 1789 1794.
9. Steinberg J, Sadaniantz A, Kron J, Krahn A, Denny D, Daubert J, Campbell B, et al. Analysis of cause specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004 109 : 1973 1980.
10. Relationship between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. The AFFIRM investigators. Circulation 2004 109 : 1509 1513.
11. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. J N Engl J Med 1998 339 : 659 666.
12. Maisel W, Stevenson L. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003 91 : 2D 8D.
13. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. J Am Med Assoc 1994 271 : 840 844.
14. Torp-Pederson C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999 341 : 857 65.
15. Zareba W. Atrial fibrillation and heart failure. Folia Cardiol 2006 13 : 443 445.
16. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998 23 : 2574 2579.
17. Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients. Heart 1997 78 : 564 8.
18. Chen SM, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. A J Am Coll Cardiol 2004 43 : 1004 1009. (Pubitemid 38352980)
19. Haissaguerre M, Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. J New Engl J Med 2004 351 : 2373 2383.
20. Tondo C, Mantica M, Russo G, Avella A, De Luca L, Pappalardo A, Fagundes R, et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol 2006 29 : 962 970.
21. Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO, Kautzner J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008 359 : 1778 1785.
22. Calkins H, Brugada J, Packer D, Cappato R, Chen S-A, Crijns HJG, Damiano RJ Jr., et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. Europace 2007 9 : 335 379.
23. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2005 112 : 154 235.
24. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999 55 : 1286 1290.
25. Wassmer G. Planning and analysing adaptive group sequential survival trials. Biom J 2006 48 : 714 729.
26. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979 35 : 549 556.